Clinical Trials Browser

OTHER × Solid Tumor × Clear all

NCT05023655 2026-03-17

Phase II Study of Tazemetostat in Solid Tumors Harboring an ARID1A Mutation

Phase 2 Terminated

Other solid neoplasm

Solid Tumor

NCT05238792 2026-03-12

Multi Tumor-Associated Antigen-Specific T Lymphocytes to Treat Patients With High Risk Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT06563375 2026-03-12

Phase 1 Dose Escalation and Dose Expansion Trial of NP-101 in Patients With Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT07450560 2026-03-10

Research on Real-time Proton Therapy Guidance Through Monitoring Proton Range Using All-digital PET

Active not recruiting

Other solid neoplasm

Solid Tumor

NCT05661201 2026-03-06

NEROFE and Doxorubicin in KRAS-mutated ST2-positive Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT05436093 2026-03-04

CLDN18.2 Targeting Nanobody Probe for PET Imaging in Solid Tumors

Phase NA Recruiting

Other solid neoplasm

Solid Tumor

NCT05645523 2026-02-25

Indocyanine Green (ICG) Guided Sentinel Lymph Node Mapping for Pediatric Visceral Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Solid Tumor

NCT05100251 2026-02-17

Clinical Trial of WBC100 on Advanced Solid Tumor

Phase 1 Terminated

Other solid neoplasm

Solid Tumor

NCT05390827 2026-02-09

Remote Digital Physiologic Data Collection in Cancer: An MSK Registry Protocol

Other solid neoplasm

Solid Tumor

NCT07225088 2026-01-26

DESCANSO, a Mental Health Intervention for Depression, Insomnia, and Fatigue Symptoms in Latino People With Cancer

Phase NA Recruiting

Other solid neoplasm

Solid Tumor

NCT03875287 2026-01-12

Dose-Escalation Study of E7727, an Oral Cytidine Deaminase Inhibitor With Oral Decitabine in Subjects With Solid Tumors

Phase 1 Active not recruiting

Other solid neoplasm

Solid Tumor

NCT07137312 2025-12-23

Ex Vivo Expansion (ACT-X)

Other solid neoplasm

Solid Tumor

NCT06349837 2025-12-17

Safety and Tolerability of LDRT Plus Concurrent Partial SBRT and Tislelizumab in Patients With Bulky Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT05522491 2025-12-11

Olaparib in the Treatment of BRCA1/2 Unmutated and BRCA1 Promoter Methylated Recurrent and Metastatic Triple-negative Breast Cancer

Phase 2 Not yet recruiting

Other solid neoplasm

Solid Tumor

NCT05525767 2025-12-11

Chemotherapy Combined With Bevacizumab Neoadjuvant Therapy for HER2-negative Breast Cancer

Phase 4 Recruiting

Other solid neoplasm

Solid Tumor

NCT04276376 2025-12-01

ARIANES

Phase 2 Terminated

Other solid neoplasm

Solid Tumor

NCT04942717 2025-11-26

Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values

Phase NA Recruiting

Other solid neoplasm

Solid Tumor

NCT07245901 2025-11-24

Safety and Tolerability of a mRNA Vaccine Encoding Tumor-Specific Circular RNA Antigens in Combination With Anti-PD-1 Monoclonal Antibody in Patients With Advanced Solid Tumors

Phase 1/2 Not yet recruiting

Other solid neoplasm

Solid Tumor

NCT05585684 2025-11-20

Liquid Biopsy-informed Precision Oncology Study to Evaluate Utility of Plasma Genomic Profiling for Therapy Selection

Other solid neoplasm

Solid Tumor

NCT06310655 2025-11-10

PARTy

Phase NA Completed

Other solid neoplasm

Solid Tumor

NCT04381806 2025-10-29

Phase I Study in Advanced Malignancies With 5-ALA

Phase 1 Suspended

Other solid neoplasm

Solid Tumor

NCT06576037 2025-10-15

Phase Ib Study of CBP-1019 in Combination With FOLFOX +/- Bevacizumab, Pembrolizumab, or Enzalutamide for Metastatic TRPV6-overexpressing Solid Tumors of Epithelial Origin

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT01239381 2025-09-30

Individualized Stereotactic Body Radiotherapy of Liver Metastases

Phase NA Completed

92 enrolled 13 charts

Other solid neoplasm

Solid Tumor

NCT02992210 2025-09-08

Study on GD2 Positive Solid Tumors by 4SCAR-GD2

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor

NCT07107633 2025-08-06

A Phase II Clinical Study to Evaluate the Efficacy and Safety of Technetium [99mtc]-H7ND Injection in the Diagnosis of Peritoneal Metastasis of Gastrointestinal Malignant Tumor.

Phase 2 Recruiting

Other solid neoplasm

Solid Tumor

NCT05206942 2025-08-01

Serial Ultrasound of Solid Tumor Lesions to Detect Early Response to Cancer Immunotherapy

Phase NA Recruiting

Other solid neoplasm

Solid Tumor

NCT06383598 2025-07-15

PD-L1 Specific 68Ga-THP-PD-L1-3 Probe for PET Imaging in Solid Tumors

Phase NA Recruiting

Other solid neoplasm

Solid Tumor

NCT07046702 2025-07-15

68Ga-MY6349 PET/CT in Solid Tumors

Other solid neoplasm

Solid Tumor

NCT05301101 2025-06-29

REDIRICT

Phase NA Recruiting

Other solid neoplasm

Solid Tumor

NCT02806388 2025-06-13

IMPACT

Other solid neoplasm

Solid Tumor

NCT06883149 2025-06-10

PIN in Combination With Anti-PD1 in Previously Treated Solid Tumor

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT02608385 2025-06-08

Study of PD1 Blockade by Pembrolizumab With Stereotactic Body Radiotherapy in Advanced Solid Tumors

Phase 1 Active not recruiting

Other solid neoplasm

Solid Tumor

NCT04671901 2025-05-28

A Study of Romiplostim to Prevent Low Platelet Counts in Children and Young Adults Receiving Chemotherapy for Solid Tumors

Phase 2 Terminated

2 enrolled 4 charts

Other solid neoplasm

Solid Tumor

NCT06956248 2025-05-04

IMPACT-INSPIRE

Other solid neoplasm

Solid Tumor

NCT04762862 2025-04-10

QUANTACT

Enrolling by invitation

Other solid neoplasm

Solid Tumor

NCT03707808 2025-01-20

myDAvIpNi

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor

NCT04105777 2025-01-06

PEKANNUSS

Other solid neoplasm

Solid Tumor

NCT06719856 2024-12-27

MMP14(MT1-MMP) Targeting Bicyclic Peptide Probe for PET Imaging in Solid Tumors

Not yet recruiting

Other solid neoplasm

Solid Tumor

NCT06720298 2024-12-27

CD147 Targeting Peptide Probe for PET Imaging in Solid Tumors

Not yet recruiting

Other solid neoplasm

Solid Tumor

NCT06739395 2024-12-18

Precision Medicine Trial Based on Molecular Matching Therapy for Patients With Standard Treatment Exhaustion

Phase 2 Recruiting

Other solid neoplasm

Solid Tumor

NCT04260269 2024-12-12

CardioSwitch

Enrolling by invitation

Other solid neoplasm

Solid Tumor

NCT06646952 2024-12-05

CD147 Targeting Nanobody Probe for PET Imaging in Solid Tumors

Other solid neoplasm

Solid Tumor

NCT06541301 2024-11-19

PICCHEST

Phase NA Not yet recruiting

Other solid neoplasm

Solid Tumor

NCT05359718 2024-11-14

PICO SM

Other solid neoplasm

Solid Tumor

NCT06515626 2024-09-25

Genetically Modified T Cells Treating Malignant Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Solid Tumor

NCT05831033 2024-09-19

Safety and Efficacy of an Autologous Tumor Infiltrating Lymphocyte (TIL) Therapy in Patients with Advanced Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Solid Tumor

NCT04185831 2024-08-22

MEGALiT

Phase 2 Active not recruiting

Other solid neoplasm

Solid Tumor

NCT06429891 2024-08-22

Research on Early Diagnosis and Clinical Transformation of Nuclide Probe Based on Bioorthogonal-gastric Cancer Mucin Target Visualization

Phase NA Recruiting

Other solid neoplasm

Solid Tumor

NCT06537505 2024-08-05

A Study of Microwave Ablation Combined With Immunotherapy ± Anti-angiogenic Drugs in the Treatment of Solid Tumors

Phase 2 Not yet recruiting

Other solid neoplasm

Solid Tumor

NCT06394622 2024-05-01

A Clinical Research About CD70-targeted CAR-NKT Cells Therapy Advanced Malignant Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor